Literature DB >> 34206213

miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage.

Ben Mead1, Alicia Kerr2, Naoki Nakaya2, Stanislav I Tomarev2.   

Abstract

The purpose of this study was to characterize the miRNA profile of purified retinal ganglion cells (RGC) from healthy and diseased rat retina. Diseased retina includes those after a traumatic optic nerve crush (ONC), and after ocular hypertension/glaucoma. Rats were separated into four groups: healthy/intact, 7 days after laser-induced ocular hypertension, 2 days after traumatic ONC, and 7 days after ONC. RGC were purified from rat retina using microbeads conjugated to CD90.1/Thy1. RNA were sequenced using Next Generation Sequencing. Over 100 miRNA were identified that were significantly different in diseased retina compared to healthy retina. Considerable differences were seen in the miRNA expression of RGC 7 days after ONC, whereas after 2 days, few changes were seen. The miRNA profiles of RGC 7 days after ONC and 7 days after ocular hypertension were similar, but discrete miRNA differences were still seen. Candidate mRNA showing different levels of expression after retinal injury were manipulated in RGC cultures using mimics/AntagomiRs. Of the five candidate miRNA identified and subsequently tested for therapeutic efficacy, miR-194 inhibitor and miR-664-2 inhibitor elicited significant RGC neuroprotection, whereas miR-181a mimic and miR-181d-5p mimic elicited significant RGC neuritogenesis.

Entities:  

Keywords:  glaucoma; miRNA; optic neuropathy; retinal ganglion cells

Year:  2021        PMID: 34206213     DOI: 10.3390/cells10071564

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  40 in total

1.  Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve.

Authors:  M Berry; J Carlile; A Hunter
Journal:  J Neurocytol       Date:  1996-02

2.  Neurotoxic reactive astrocytes are induced by activated microglia.

Authors:  Shane A Liddelow; Kevin A Guttenplan; Laura E Clarke; Frederick C Bennett; Christopher J Bohlen; Lucas Schirmer; Mariko L Bennett; Alexandra E Münch; Won-Suk Chung; Todd C Peterson; Daniel K Wilton; Arnaud Frouin; Brooke A Napier; Nikhil Panicker; Manoj Kumar; Marion S Buckwalter; David H Rowitch; Valina L Dawson; Ted M Dawson; Beth Stevens; Ben A Barres
Journal:  Nature       Date:  2017-01-18       Impact factor: 49.962

3.  MicroRNA Expression in the Glaucomatous Retina.

Authors:  Hari Jayaram; William O Cepurna; Elaine C Johnson; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

4.  MicroRNA-664-5p promotes myoblast proliferation and inhibits myoblast differentiation by targeting serum response factor and Wnt1.

Authors:  Rui Cai; Naren Qimuge; Meilin Ma; Yingqian Wang; Guorong Tang; Que Zhang; Yunmei Sun; Xiaochang Chen; Taiyong Yu; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

5.  Cyan fluorescent protein (CFP) expressing cells in the retina of Thy1-CFP transgenic mice before and after optic nerve injury.

Authors:  Xu Wang; Michele L Archibald; Kelly Stevens; William H Baldridge; Balwantray C Chauhan
Journal:  Neurosci Lett       Date:  2009-10-29       Impact factor: 3.046

6.  Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma.

Authors:  Xin-Gang Nie; Dong-Sheng Fan; Yan-Xia Huang; Ying-Ying He; Bo-Li Dong; Feng Gao
Journal:  Am J Physiol Cell Physiol       Date:  2018-09-05       Impact factor: 4.249

Review 7.  Extracellular vesicle therapy for retinal diseases.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Prog Retin Eye Res       Date:  2020-03-10       Impact factor: 19.704

Review 8.  miR-708-5p: a microRNA with emerging roles in cancer.

Authors:  Nicholas J Monteleone; Carol S Lutz
Journal:  Oncotarget       Date:  2017-08-01

9.  miR-181a/b downregulation exerts a protective action on mitochondrial disease models.

Authors:  Alessia Indrieri; Sabrina Carrella; Alessia Romano; Alessandra Spaziano; Elena Marrocco; Erika Fernandez-Vizarra; Sara Barbato; Mariateresa Pizzo; Yulia Ezhova; Francesca M Golia; Ludovica Ciampi; Roberta Tammaro; Jorge Henao-Mejia; Adam Williams; Richard A Flavell; Elvira De Leonibus; Massimo Zeviani; Enrico M Surace; Sandro Banfi; Brunella Franco
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 14.260

Review 10.  The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer.

Authors:  Alessia Indrieri; Sabrina Carrella; Pietro Carotenuto; Sandro Banfi; Brunella Franco
Journal:  Int J Mol Sci       Date:  2020-03-18       Impact factor: 5.923

View more
  1 in total

1.  miR-181d-5p Protects against Retinal Ganglion Cell Death after Blunt Ocular Injury by Regulating NFIA-Medicated Astrocyte Development.

Authors:  Jinghua Li; Junyi Liu; Yuanping Zhang; Xu Zha; Hong Zhang; Yongying Tang; Xueying Zhao
Journal:  Mediators Inflamm       Date:  2022-10-08       Impact factor: 4.529

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.